ISRCTN64663470已完成不适用
A pilot study to Inform a multi-centre randomised controlled trial of an impedance threshold device (ITD) – the ResQPOD, to improve survival outcomes in cardiac arrest patients (the POD pilot study)
ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 120 人开始时间: 2018年11月8日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adults aged 18 or older with an unexpected cardiorespiratory arrest
- •2. Primary cardiac origin was suspected, in the absence of trauma, known terminal illness or other external cause such as self-harm
- •3. Resuscitation attempt in accordance with normal NEAS policy
排除标准
- •1. Age 17 or under
- •2. Do Not Attempt Resuscitation decision
- •3. NEAS Recognition of Life Extinct policy applied
- •4. ROSC prior to use of device
- •5. Pregnant, known or clinically suspected
- •6. Suspected non-cardiac origin
- •7. Trauma, suicide
研究者
相似试验
已完成
不适用
A pilot multi-centre randomised controlled trial of sequential treatment with Mitoxantrone and Glatiramer Acetate vs Interferon Beta-1a in early active relapsing remitting Multiple SclerosisISRCTN31557558Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
进行中（未招募）
1 期
A pilot multi-centre randomised controlled trial of sequential treatment with Mitoxantrone and Glatiramer Acetate vs. Interferon Beta-1a in early active relapsing remitting Multiple Sclerosis. - UNKEMPTEarly, active relapsing remitting Multiple Sclerosis (RRMS)EUCTR2004-004903-39-GBThe Walton Centre for Neurology and Neurosurgery60
招募中
不适用
Australasian Follow-up Tracking and Enhancing Recovery after Acute Kidney Injury (AFTER-AKI)Renal and Urogenital - Kidney diseaseAcute kidney injuryACTRN12618002044202Austin Health200
进行中（未招募）
不适用
A randomised controlled multicentre study for the safety of Depigoid(R)rush scheduleRhinitis and/or rhinoconjunctivitis without uncontrolled asthma caused by clinical relevant sensitisation againts tree pollen, grass pollen or house dust mitesMedDRA version: 8.0Level: LLTClassification code 10001723EUCTR2005-001584-66-DEETI Pharma GmbH320
进行中（未招募）
1 期
A study to assess the efficacy and safety of the withdrawal of nucleos/tide analogues with resistance in multitreated HIV-1-infected subjects with virological suppressioEUCTR2012-000198-21-ESFundació Lluita contra la SIDA90